This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Record Use Of At-the-Market (ATM) Offerings Continues In 2013 With $161 Million Raised By U.S. Life Sciences Companies In First Quarter, Reports Brinson Patrick

NEW YORK, May 28, 2013 /PRNewswire/ --  Brinson Patrick Securities Corporation, a boutique investment bank specializing in at-the-market (ATM) offerings, reported today that U.S. life sciences companies raised $161 million through ATMs in the first quarter of 2013, compared to $112 million in the first quarter of 2012.

(Logo: )

The $161 million raised is a new record for quarterly ATM usage by U.S. life sciences companies. The proceeds raised are 25% more than the previous record of $129 million, which was raised in the fourth quarter of 2012. Life sciences companies whose ATMs were active in the first quarter included: Delcath Systems, Inc. (NASDAQ: DCTH), New York, NY; Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR), Aliso Viejo, CA; Raptor Pharmaceuticals, Inc.  (NASDAQ: RPTP), Novato, CA; Coronado Biosciences, Inc. (NASDAQ: CNDO), Burlington, MA.

"We are continuing to see new records in ATM usage for life sciences companies," said Todd Wyche, CEO of Brinson Patrick. "This is the third consecutive quarter where the proceeds raised set a record high for the industry."

An ATM provides an efficient means of raising equity capital over time by enabling a publicly traded company to tap into the existing secondary market for its shares on an as-needed basis. With an ATM, an exchange-listed company incrementally sells newly issued shares into the trading market through a designated broker-dealer at prevailing market prices, rather than via a traditional underwritten offering of a fixed number of shares at a fixed price all at once. ATMs are also generally less expensive and less complicated to execute than traditional equity offerings and do not require a lot of executive time.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,812.19 +19.51 0.11%
S&P 500 2,089.14 +2.55 0.12%
NASDAQ 5,102.8080 +0.33 0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs